pegcantratinib: Clinical Trials

2 trials of pegcantratinib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow pegcantratinib: new trials by email Literature Review of pegcantratinib trials Research Report on pegcantratinib

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate the Pharmacodynamic Effects of CT327 on Intra-dermal Nerve Growth Factor (NGF) and Evoked Pain Responses, in Healthy Male Volunteers
CT327 (or placebo) followed by placebo (or CT327) - Neuropathic Pain
Phase 1CompletedCreabilis SA242011-01-012011-06-08
A Study to Assess the Pharmacokinetics, Safety and Tolerability of CT327 in Healthy Male Volunteers
0.01% CT327 (or placebo), 0.001% CT327 (or placebo) - Safety
Phase 1CompletedCreabilis SA162007-09-012010-11-18

Conditions studied

Neuralgia (1)

Sponsors

Creabilis SA (2)

Countries

Denmark (1)